Cefprozil
AURO-CEFPROZIL
- Dosage form
- Tablet
- Available strengths
- 250 mg, 500 mg (tablets); 125 mg/5 mL, 250 mg/5 mL (oral suspension)
- Drug class
- Cephalosporin antibiotic (second-generation)
- Common brand
- AURO-CEFPROZIL
Clinical overview. Cefprozil is a second-generation cephalosporin antibiotic used to treat bacterial infections of the ear, sinuses, throat, skin, and urinary tract. It can be taken with or without food and is available as tablets or an oral suspension. Common side effects include diarrhea, nausea, and rash, while serious risks include allergic reactions and C. difficile-associated diarrhea.
Indication
Common therapeutic uses
- Cefprozil treats pharyngitis and tonsillitis caused by group A streptococcus.
- Cefprozil treats middle ear infections (otitis media) in children.
- Cefprozil treats acute bacterial sinusitis.
- Cefprozil treats uncomplicated skin and skin-structure infections.
- Cefprozil treats uncomplicated urinary tract infections, including acute cystitis.
Pregnancy
Risk assessment and monitoring considerations
- Animal studies with cefprozil have not shown harm to the fetus, but there are no adequate controlled studies in pregnant women.
- Cefprozil should be used during pregnancy only if the expected benefit justifies the potential risk.
Breastfeeding
Infant exposure considerations
- Less than 1% of a maternal dose of cefprozil passes into breast milk.
- Caution is advised when cefprozil is used by a nursing mother, and temporary use of formula feeding may be considered.
Geriatrics
Dosing and tolerability considerations
- Cefprozil has not been specifically studied in frail or institutionalized elderly patients.
- Older adults may have reduced kidney clearance of cefprozil even with normal blood test results, so a lower dose or longer interval between doses may be needed.
Pediatrics
Use in children and adolescents
- Cefprozil is approved for use in infants 6 months of age and older for ear infections, and in children 2 years and older for other approved infections.
- Safety and effectiveness have not been established in infants under 6 months old.
- Pediatric dosing is calculated by body weight and should not exceed the maximum adult daily dose.
Dosage & Administration
Practical dosing and administration
- For pharyngitis and tonsillitis in adults, the usual dose is 500 mg once daily.
- For acute sinusitis in adults, the usual dose is 250 mg or 500 mg every 12 hours.
- For uncomplicated skin infections in adults, the usual dose is 250 mg every 12 hours or 500 mg once daily.
- For uncomplicated urinary tract infections in adults, the usual dose is 500 mg once daily.
- For skin infections in children 2 to 12 years, the usual dose is 20 mg/kg once daily based on weight.
- For otitis media in infants and children 6 months to 12 years, the usual dose is 15 mg/kg every 12 hours.
- For pharyngitis and tonsillitis in infants and children 6 months to 12 years, the usual dose is 7.5 mg/kg every 12 hours.
- The maximum pediatric daily dose should never exceed the adult maximum of 1 gram per day.
- Treatment usually continues for 10 to 15 days depending on the infection, though uncomplicated bladder infections may need only 7 days and streptococcal infections need at least 10 days to prevent complications such as rheumatic fever.
- In patients with creatinine clearance of 30 mL/min or less, the dose should be reduced by half and given at the standard interval; patients on hemodialysis should receive their dose after the dialysis session.
Overdose
Recognizing and responding to overdose
If overdose is suspected, seek emergency medical attention immediately or contact your regional Poison Control Centre without delay.
- No cases of cefprozil overdose have been reported, so specific overdose symptoms are not established.
- Because cefprozil is eliminated primarily by the kidneys, hemodialysis can help remove the drug from the body in cases of severe overdose, particularly in patients with reduced kidney function.
- High doses of cephalosporin antibiotics have been linked to seizures, especially in patients with impaired kidney function whose dose was not adjusted.
Common side effects
Frequently reported tolerability concerns
- Diarrhea may occur.
- Nausea may occur.
- Vomiting may occur.
- Skin rash may occur.
- Abdominal pain may occur.
- Genital itching or vaginal yeast infection may occur, more often in children.
- Headache, dizziness, or trouble sleeping may occur.
Serious side effects
Findings that may require urgent assessment
Serious side effects require immediate discussion with the prescriber or emergency care.
- Severe allergic reactions, including anaphylaxis, can occur and may require emergency treatment.
- Severe diarrhea caused by Clostridioides difficile colitis can develop, sometimes weeks after finishing treatment.
- Cefprozil should not be used in anyone with a history of hemolytic anemia linked to a cephalosporin antibiotic, as recurrence can be more severe.
- Serious skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported.
- Liver problems, including hepatitis and jaundice, have been reported rarely.
- Seizures can occur, particularly in patients with kidney impairment who receive too high a dose.
- Low platelet counts and other blood cell abnormalities have been reported.
- Seek urgent medical attention for difficulty breathing, facial swelling, severe rash, persistent diarrhea, or signs of a serious allergic reaction.
Use with caution
Situations requiring closer assessment
- Use with caution in patients with a history of penicillin allergy, since cross-reactivity with cephalosporins can occur in some patients.
- Use with caution in patients with reduced kidney function, and adjust the dose accordingly.
- Use with caution in patients with a history of gastrointestinal disease, particularly colitis.
- Use with caution in patients receiving potent diuretics, as cephalosporins combined with these agents may affect kidney function.
- Use with caution in patients taking aminoglycoside antibiotics, due to increased risk of kidney and hearing toxicity.
- Use with caution in people with phenylketonuria, since the oral suspension contains aspartame.
Contraindications
Situations where therapy may be inappropriate
- Contraindicated in patients with known hypersensitivity to cefprozil.
- Contraindicated in patients allergic to other cephalosporin antibiotics.
Drug interactions
Clinically relevant combinations
- Probenecid can double blood levels of cefprozil by slowing its elimination.
- Aminoglycoside antibiotics combined with cefprozil may increase the risk of kidney damage, especially with high doses or prolonged use.
- Cefprozil may cause false-positive results on older urine glucose tests that use copper reduction methods, such as Benedict's or Clinitest; enzyme-based glucose tests are not affected.
Food interactions
Meal-related administration
- Cefprozil can be taken with or without food; the presence of food does not affect how much of the drug is absorbed.
Time of administration
Practical scheduling
- Cefprozil tablets and suspension can be taken at any time of day, with or without meals, since food does not affect absorption.
Storage
Product handling
- Store cefprozil tablets at room temperature, protected from light and excessive humidity.
- Store the unmixed suspension powder at room temperature, protected from light and moisture.
- Once mixed, store the suspension in the refrigerator and discard any unused portion after 14 days.
Patient take-away
Key counselling points for a quick closing summary
- Complete the full course of cefprozil exactly as prescribed, even if symptoms improve early.
- Cefprozil treats bacterial infections only and will not work against colds, flu, or other viral illnesses.
- Contact your pharmacist or doctor promptly if you develop a rash, severe diarrhea, or signs of an allergic reaction.
References
Source material and product information
For professional reference. Confirm patient-specific decisions against the current approved product monograph and applicable clinical guidance.